Targeted Accumulation of Macrophages Induced by Microbeam Irradiation in a Tissue-Dependent Manner.

DNA damage infiltration macrophages microbeam radiotherapy

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
22 Mar 2022
Historique:
received: 15 02 2022
revised: 08 03 2022
accepted: 18 03 2022
entrez: 23 4 2022
pubmed: 24 4 2022
medline: 24 4 2022
Statut: epublish

Résumé

Radiation therapy (RT) is a vital component of multimodal cancer treatment, and its immunomodulatory effects are a major focus of current therapeutic strategies. Macrophages are some of the first cells recruited to sites of radiation-induced injury where they can aid in tissue repair, propagate radiation-induced fibrogenesis and influence tumour dynamics. Microbeam radiation therapy (MRT) is a unique, spatially fractionated radiation modality that has demonstrated exceptional tumour control and reduction in normal tissue toxicity, including fibrosis. We conducted a morphological analysis of MRT-irradiated normal liver, lung and skin tissues as well as lung and melanoma tumours. MRT induced distinct patterns of DNA damage, reflecting the geometry of the microbeam array. Macrophages infiltrated these regions of peak dose deposition at variable timepoints post-irradiation depending on the tissue type. In normal liver and lung tissue, macrophages clearly demarcated the beam path by 48 h and 7 days post-irradiation, respectively. This was not reflected, however, in normal skin tissue, despite clear DNA damage marking the beam path. Persistent DNA damage was observed in MRT-irradiated lung carcinoma, with an accompanying geometry-specific influx of mixed M1/M2-like macrophage populations. These data indicate the unique potential of MRT as a tool to induce a remarkable accumulation of macrophages in an organ/tissue-specific manner. Further characterization of these macrophage populations is warranted to identify their organ-specific roles in normal tissue sparing and anti-tumour responses.

Identifiants

pubmed: 35453485
pii: biomedicines10040735
doi: 10.3390/biomedicines10040735
pmc: PMC9025837
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Swiss National Science Foundation
ID : 31003A_176038
Pays : Switzerland
Organisme : Swiss Cancer League
ID : KFS-4281-08-2017
Organisme : Bernische Krebsliga
ID : 190

Références

Nat Rev Cancer. 2008 Dec;8(12):957-67
pubmed: 19005492
Nat Rev Clin Oncol. 2017 Jun;14(6):365-379
pubmed: 28094262
J Hepatol. 2014 May;60(5):1090-6
pubmed: 24412603
Biomedicines. 2020 Oct 30;8(11):
pubmed: 33142986
J Immunol. 2014 Jul 1;193(1):344-53
pubmed: 24890723
Cancers (Basel). 2020 Sep 17;12(9):
pubmed: 32957691
Clin Oncol (R Coll Radiol). 2021 Nov;33(11):705-712
pubmed: 34454806
Circ Res. 2016 Jul 22;119(3):414-7
pubmed: 27458196
Int J Radiat Oncol Biol Phys. 2016 Aug 1;95(5):1485-1494
pubmed: 27325483
Lancet Oncol. 2009 Jul;10(7):718-26
pubmed: 19573801
Oncoimmunology. 2018 Jul 23;7(10):e1494488
pubmed: 30288363
Cancer Lett. 2015 Nov 28;368(2):198-208
pubmed: 25592036
Cureus. 2021 Nov 6;13(11):e19317
pubmed: 35223216
Nat Immunol. 2013 Oct;14(10):986-95
pubmed: 24048120
Cancers (Basel). 2021 Apr 27;13(9):
pubmed: 33925455
Radiat Res. 2020 Dec 1;194(6):678-687
pubmed: 32991732
Front Immunol. 2017 Jul 14;8:828
pubmed: 28769933
Hepatology. 2015 Jul;62(1):279-91
pubmed: 25810240
Eur Respir J. 2018 Mar 1;51(3):
pubmed: 29496785
J Exp Med. 2017 Aug 7;214(8):2387-2404
pubmed: 28694385
Radiat Res. 2013 Feb;179(2):135-45
pubmed: 23237586
Sci Rep. 2016 Sep 19;6:33601
pubmed: 27640676
Cancer Lett. 2015 Nov 28;368(2):230-7
pubmed: 25888451
Oncoimmunology. 2014 Apr 25;3:e28518
pubmed: 25071979
Cancers (Basel). 2020 Oct 29;12(11):
pubmed: 33138341
Int J Mol Sci. 2021 Jul 20;22(14):
pubmed: 34299373
Radiat Res. 2014 Aug;182(2):149-62
pubmed: 25036982
Cancer Res. 2010 Jul 15;70(14):5728-39
pubmed: 20570887
Mol Med Rep. 2020 Nov;22(5):4107-4115
pubmed: 33000214
Int J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):1126-1136
pubmed: 31461675
Science. 2011 Jun 10;332(6035):1284-8
pubmed: 21566158
J Exp Med. 2015 Apr 6;212(4):447-56
pubmed: 25800956
Cell. 2016 Apr 21;165(3):668-78
pubmed: 27062926
J Invest Dermatol. 2002 Feb;118(2):327-34
pubmed: 11841552
Biochem Pharmacol. 2013 Sep 15;86(6):836-43
pubmed: 23876342
Cancers (Basel). 2021 Feb 24;13(5):
pubmed: 33668110
Cancer Res. 2008 Jan 15;68(2):450-6
pubmed: 18199539
Cancer Cell. 2013 Nov 11;24(5):589-602
pubmed: 24209604
Front Oncol. 2018 Jun 25;8:235
pubmed: 29988496
Front Oncol. 2012 Sep 11;2:116
pubmed: 22973558
Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1184-1193
pubmed: 30529375
Cell Mol Immunol. 2021 Jan;18(1):45-56
pubmed: 33041338
Front Oncol. 2021 May 25;11:644400
pubmed: 34113566
J Immunol. 2007 Sep 15;179(6):3488-94
pubmed: 17785782
Nat Med. 2004 Feb;10(2):145-7
pubmed: 14745444
Cancers (Basel). 2021 Apr 18;13(8):
pubmed: 33919517
EBioMedicine. 2020 Jul;57:102833
pubmed: 32574956
Nat Commun. 2018 Oct 22;9(1):4383
pubmed: 30348985
J Radiat Res. 1995 Jun;36(2):125-33
pubmed: 7473345
Cancer Res. 2017 Nov 15;77(22):6389-6399
pubmed: 29113972
Int J Radiat Oncol Biol Phys. 2021 Dec 1;111(5):1276-1288
pubmed: 34364976
Transl Res. 2018 Jan;191:64-80
pubmed: 29175267
Clin Dev Immunol. 2013;2013:281958
pubmed: 23653658
Am J Physiol Lung Cell Mol Physiol. 2014 Apr 15;306(8):L709-25
pubmed: 24508730
J Pathol. 2014 Feb;232(3):289-99
pubmed: 24254983
Radiother Oncol. 2019 Apr;133:93-99
pubmed: 30935588
Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):886-94
pubmed: 20510199
J Thorac Oncol. 2015 Dec;10(12):1703-12
pubmed: 26709479
Immunol Rev. 2014 Nov;262(1):36-55
pubmed: 25319326
Oncotarget. 2017 Aug 7;8(42):72597-72612
pubmed: 29069812
J Biol Chem. 1998 Mar 6;273(10):5858-68
pubmed: 9488723
Nat Rev Immunol. 2017 May;17(5):306-321
pubmed: 28317925
Int J Radiat Oncol Biol Phys. 1980 Mar;6(3):345-7
pubmed: 7390907
Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):680-689
pubmed: 29559293

Auteurs

Verdiana Trappetti (V)

Institute of Anatomy, University of Bern, Baltzerstarsse 2, 3012 Bern, Switzerland.

Jennifer Fazzari (J)

Institute of Anatomy, University of Bern, Baltzerstarsse 2, 3012 Bern, Switzerland.

Cristian Fernandez-Palomo (C)

Institute of Anatomy, University of Bern, Baltzerstarsse 2, 3012 Bern, Switzerland.

Lloyd Smyth (L)

Department of Obstetrics and Gynaecology, Royal Women's Hospital, University of Melbourne, Melbourne, VIC 3052, Australia.

Marine Potez (M)

Institute of Anatomy, University of Bern, Baltzerstarsse 2, 3012 Bern, Switzerland.
Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, 12902 USF Magnolia Drive, Tampa, FL 33612, USA.

Nahoko Shintani (N)

Institute of Anatomy, University of Bern, Baltzerstarsse 2, 3012 Bern, Switzerland.

Bettina de Breuyn Dietler (B)

Institute of Anatomy, University of Bern, Baltzerstarsse 2, 3012 Bern, Switzerland.

Olga A Martin (OA)

Institute of Anatomy, University of Bern, Baltzerstarsse 2, 3012 Bern, Switzerland.
Division of Radiation Oncology, Peter MacCallum Cancer Centre, 305 Grattan St., Melbourne, VIC 3000, Australia.
Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia.

Valentin Djonov (V)

Institute of Anatomy, University of Bern, Baltzerstarsse 2, 3012 Bern, Switzerland.

Classifications MeSH